ANI Pharmaceuticals | ANIP - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
AbbVie USD 3.63B 54M 2026-06
ANI Pharmaceuticals USD 73.66M 9.14M 2026-03
Aurora Cannabis CAD 41.4M 781K 2026-03
Canopy Growth CAD 31.17M 2.27M 2026-03
Eli Lilly USD 3.43B 496M 2026-06
Emergent BioSolutions USD 182.8M 82.3M 2023-06
Heron Therapeutics USD 23.74M 605K 2025-12
Hikma Pharmaceutical USD 288M 149M 2025-12
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Nektar Therapeutics USD 11.87M 1.7M 2026-03
Novartis USD 3.14B 296M 2026-03
Omeros USD 11.32M 2.48M 2024-09
Perrigo USD 3.28B 3.02B 2026-06
Sun Pharmaceuticals INR 24.89B 637.6M 2025-03
Teva Pharmaceutical Industries USD 1.03B 34M 2026-06